Reid Hoffman Bets on A.I. Drug Discovery with a Pulitzer-Winning Cancer Physician
Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.
Hallucinations in LLMs refer to instances where models generate plausible yet incorrect or unrelated information.
Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.
After striking similar deals with Northwestern and UIC, Deerfield Management aims to help the University of Chicago turn more ...
AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.
Configurable informatics platform improves lab efficiency, data tracking, and resource management from plasmid to structure ...
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today. The rally ...
Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...
ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback